Head-to-head · WeighScore
Cabana vs HealthRX
By GLP-1 ScorecardUpdated
Score comparison
HealthRX has the higher recorded score — 77.5/100 to 56.5/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.
Before you choose
Cabana does not publish a semaglutide price, so its Cabana review sets out what it does disclose, while the HealthRX review explains the conditions attached to HealthRX's figure. The semaglutide cost page compares published rates across the field. Ask Cabana for a written total before treating either one as the cheaper choice.
If neither one fits, Cabana vs MadeMed and Carocare Wellness vs HealthRX compare each of them with another graded program, and the list of alternatives to Cabana ranks the programs closest to Cabana on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Cabana | HealthRX |
|---|---|---|
| WeighScore | 56.5/100 | 77.5/100 |
| Grade | C | C+ |
| Site position | #443 | #34 |
| Semaglutide | Not disclosed | $39 first month, then $125/month on a 3-month plan ($115 on 6 months, $97 on 12); month to month $109 first month, then $139/month |
| Tirzepatide | Not disclosed | $39 first month, then $219/month on a 3-month plan ($179 on 6 months, $159 on 12); month to month $109 first month, then $239/month |
| Coverage | Coverage not published | All 50 states claimed; subject to clinical eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Not confirmed |
Strengths
- Public catalog identifies semaglutide injections and tablets and tirzepatide injections
- Semaglutide injection page describes membership and concierge support
What to consider
- No selected product price, continuing charge or assigned dispensing pharmacy verified
- The refund policy says prescription sales are final and does not specify the last chance to stop an in-progress order
Strengths
- First payment and recurring monthly charge shown together for every plan
- Medication if prescribed, review, instructions and overnight shipping included; no separate GLP-1 membership fee stated
- A month-to-month option carries no minimum term
- Full refund promised if clinical approval is declined
What to consider
- On 3-, 6- and 12-month plans the remaining monthly payments stay due after an early cancellation
- Assigned medical practice and dispensing pharmacy not named on reviewed public pages
- Refund promises for unshipped doses need reconciliation with restrictions after dispensing
- Injection supplies, clinical response time and monitoring cadence unconfirmed
Featured provider
HealthRX
Factor scores not reassessed.HealthRX scores 77.5/100 (C+). HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.